Neurotech industry news
Funding rounds, product launches, research findings, and policy updates — published 3× per week.
ReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics
European neurotech startup ReVision Implant has closed a €4 million funding round to develop its visual cortex implant technology.
2026-07-25
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
Catalio-backed neuroscience startup Flourish has launched publicly with investment from Bezos Expeditions and Google Ventures.
2026-07-24
Science Corp. Launches Prima BCI Implant in Europe, Bringing Vision Restoration to a New Market
Science Corp. has launched its Prima vision-restoring BCI implant in Europe, marking a significant commercial milestone for photovoltaic retinal technology.
2026-07-23
First Able-Bodied Individuals Receive Brain-Computer Implants in Landmark Expansion of BCI Eligibility
Able-bodied individuals have received brain-computer interface implants for the first time, marking a major shift in BCI trial eligibility criteria.
2026-07-22
Closed-Loop BCIs Charted as Next Frontier for Depression, Anxiety, and PTSD Treatment
A new roadmap outlines how closed-loop brain-computer interfaces could transform clinical care for depression, anxiety, and PTSD.
2026-07-21
Instruments of Self-Knowledge: How Cognitive Assessment Tech Is Making the Invisible Mind Measurable
A closer look at the neurotech companies turning cognition — long the most private, hardest-to-measure part of a person — into something you can actually track over time.
2026-07-21
Top 10 Technologies Turning Self-Awareness Into Something You Can Actually See
From brain-computer interfaces to biological-age testing to digital legacy platforms, a cross-industry look at the technologies making the invisible parts of a person — mind, body, story, and environment — legible.
2026-07-21
China Clears Brain-Computer Interfaces for Commercial Use, Prompting Calls for Global Regulatory Alignment
China has approved invasive BCIs for commercial use, raising urgent questions about whether a global regulatory coalition is now necessary.
2026-07-20
Brain-Machine Interface Cuts Through the Noise to Restore Conversational Clarity
A new brain-machine interface can identify and amplify targeted conversations in noisy environments, offering a significant leap for assistive communication tech.
2026-07-19
Paralyzed Man Regains Sensation Through Brain Stimulation Device in Landmark Clinical Result
A paralyzed patient has recovered tactile sensation using a brain stimulation device, marking a significant advance in closed-loop neuromodulation therapy.
2026-07-18
Neurofeedback Systems Market on Track to Nearly Triple, Hitting $2.97 Billion by 2034
The global neurofeedback systems market is forecast to reach $2.97 billion by 2034, signaling robust long-term demand across clinical and consumer segments.
2026-07-17
China Performs World's First Commercial BCI Implant, Marking a Pivotal Moment in the Global Brain-Computer Interface Race
China has completed the world's first implant of a commercial brain-computer interface, signaling a major shift in the global BCI competitive landscape.
2026-07-16
NIH Confirms Brain-Computer Device Restores Speech in Human Patient
A brain-computer interface device has enabled a man to speak again, according to new findings published by the National Institutes of Health.
2026-07-15
Neurovalens Wins FDA Approval for Wearable PTSD Therapy Aimed at US Veterans
Neurovalens has received FDA approval for its neuromodulation device to treat PTSD in US veterans, marking a significant regulatory milestone.
2026-07-14
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
European startup BRYM has secured €650K in early-stage funding to develop a wearable neurofeedback platform targeting mental wellness.
2026-07-13
Robert Wood Johnson University Hospital Hamilton Implants First Neuromodulation Device to Treat Heart Failure Symptoms
RWJ University Hospital Hamilton has performed its first neuromodulation implant targeting heart failure symptoms, marking a clinical milestone.
2026-07-12
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Target Brain Health
Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.
2026-07-11
BrainCo Pushes to Commercialize Brain-Tech as China's BCI Ambitions Come Into Focus
CNBC profiles BrainCo's commercialization drive, spotlighting China's growing ambition to compete at the frontier of brain-computer interface technology.
2026-07-10
FDA Clears PoNS Device for Stroke Rehabilitation, Broadening Neurostimulation's Clinical Reach
The FDA has cleared the PoNS neurostimulation device for stroke rehabilitation, extending its approved use beyond multiple sclerosis.
2026-07-09
Neurovalens Wins FDA Approval for PTSD Therapy Targeting US Veterans
Neurovalens has received FDA approval for its non-invasive neuromodulation therapy to treat PTSD in US veterans.
2026-07-08
University of Michigan Completes First Long-Term Wireless Brain-Computer Interface Implant in Humans
U-M neurosurgeons perform the first long-term wireless BCI implant in a human patient, marking a pivotal milestone for the field.
2026-07-07
Synchron Closes $275M Series E to Accelerate Stentrode BCI Commercialization
Synchron raises $275M Series E to expand Stentrode BCI trials and push toward FDA approval for paralysis patients.
2026-06-29
ProductIt's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
FacialDx analyzes over 13,000 facial variables and 155 biomarkers to deliver neurological wellness indicators in seconds — giving clinicians objective data for sideline concussion decisions.
2026-06-23
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
MIT's new EEG-based system decodes six discrete emotional states in real time with 94% accuracy, a landmark for non-invasive affective neuroscience.
2026-06-13
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
Synchron's Stentrode Home Edition brings endovascular BCI technology to approved patients outside hospital walls for the first time.
2026-06-11
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
Synchron's implantable brain-computer interface has now been placed in 100 patients globally, setting the stage for a pivotal FDA trial later this year.
2026-06-09
Closed-Loop Deep Brain Stimulation Demonstrates Sustained Cognitive Benefits in Landmark Alzheimer's Trial
A 24-month adaptive DBS trial reports significant memory retention improvements in early-stage Alzheimer's patients, reshaping neuromodulation research.
2026-06-04
FDA Finalizes Guidance Framework for Adaptive Neural Devices, Setting Clearer Path for BCI Approvals
The FDA's finalized guidance on adaptive neural devices establishes new evidentiary standards for BCI approvals, reshaping the regulatory landscape.
2026-05-30
Sponsored content
Reach neurotech decision-makers with your story
Sponsored articles appear in the News feed and the weekly newsletter. $1,500/article.